أخبار السوق

تابع أحدث الأخبار المالية والاقتصادية وتحديثات الأسواق والتقارير والتحليلات على PipVero.

المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
JD Sports appoints Peter Agnefjäll as chair from September

JD Sports appoints Peter Agnefjäll as chair from September

JD Sports Fashion PLC (LSE:JD., OTC:JDSPY) has appointed Peter Agnefjäll as chair of the board with effect from 1 September 2026.

الرموز ذات الصلة 1
JDSPY JDSPY
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Genel rejects £202 million cash approach from DNO

Genel rejects £202 million cash approach from DNO

Genel Energy PLC (LSE:GENL, FRA:4VL, OTC:GEGYY) has rejected a £202 million cash approach from DNO, its Norwegian rival in the Kurdistan region of Iraq. DNO has taken the proposal public after being rebuffed, a move that raises pressure on the Genel board to open talks.

الرموز ذات الصلة 1
GEGYY GEGYY
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Oxford Biomedica cuts 2026 revenue guidance as clients delay orders

Oxford Biomedica cuts 2026 revenue guidance as clients delay orders

Oxford BioMedica PLC (LSE:OXB), the cell and gene therapy manufacturer, has cut its revenue guidance for 2026 after clients deferred orders and a US site took longer than expected to come online. The company now expects full-year revenues of £180 million to £200 million.

الرموز ذات الصلة 1
OXB OXB
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: Reuters وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Israel's Ratio Petroleum sweetens Pharos Energy offer, outbidding Serica

Israel's Ratio Petroleum sweetens Pharos Energy offer, outbidding Serica

Israel-based Ratio Petroleum Energy raised its takeover bid for Pharos Energy to about £146.4 ​million ($196.97 million) on Friday, outbidding rival oil ‌producer Serica Energy and winning back the board's recommendation.

الرموز ذات الصلة 1
SOCLF SOCLF
المصدر: Reuters
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Ocugen Q2 Earnings Call Highlights

Ocugen Q2 Earnings Call Highlights

Ocugen NASDAQ: OCGN said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program.

الرموز ذات الصلة 1
OCGN OCGN
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
OmniAb Q2 Earnings Call Highlights

OmniAb Q2 Earnings Call Highlights

OmniAb NASDAQ: OABI reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and year-end cash outlook.

الرموز ذات الصلة 1
OABI OABI
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Nova Q2 Earnings Call Highlights

Nova Q2 Earnings Call Highlights

Nova NASDAQ: NVMI reported record second-quarter revenue of $255 million, up 8% sequentially and 16% from a year earlier, as demand increased across its semiconductor process-control portfolio. The company said revenue reached the high end of its guidance range, while non-GAAP diluted earnings per share of $2.51 exceeded the high end of its outlook.

الرموز ذات الصلة 1
NVMI NVMI
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Novavax Q2 Earnings Call Highlights

Novavax Q2 Earnings Call Highlights

Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant platform and continued cost reductions.

الرموز ذات الصلة 1
NVAX NVAX
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Natera Q2 Earnings Call Highlights

Natera Q2 Earnings Call Highlights

Natera NASDAQ: NTRA reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth across its oncology, women's health and organ health businesses.

الرموز ذات الصلة 1
NTRA NTRA
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Intellia Therapeutics Q2 Earnings Call Highlights

Intellia Therapeutics Q2 Earnings Call Highlights

Intellia Therapeutics NASDAQ: NTLA said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the resumption of enrollment in Phase III studies of nex-z for transthyretin amyloidosis.

الرموز ذات الصلة 1
NTLA NTLA
المصدر: MarketBeat
زيارة المصدر
تعليق
المصدر: MarketBeat وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
NETGEAR Q2 Earnings Call Highlights

NETGEAR Q2 Earnings Call Highlights

NETGEAR NASDAQ: NTGR reported second-quarter 2026 revenue of $168.6 million, down 1.2% from a year earlier but up 6.1% sequentially, as growth in its enterprise segment offset continued pressure in consumer products. The company said revenue and non-GAAP operating margin exceeded the high end of its guidance range.

الرموز ذات الصلة 1
NTGR NTGR
المصدر: MarketBeat
زيارة المصدر
تعليق